FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Endocrinology Advisor19h
FDA Approves Merilog, a Rapid-Acting Insulin Biosimilar Product
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
C&EN20d
Glucose-Responsive Materials for Smart Insulin Delivery: From Protein-Based to Protein-Free Design
Department of Bioscience and Biomedical Engineering, Indian Institute of Technology-Bhilai, Durg, 491002, CG India Department of Chemistry, Indian Institute of Technology-Bhilai, Durg, 491002, CG ...
Star Tribune23d
Minnesota reaches Novo Nordisk settlement, locks in insulin at $35 per month
In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...
Reuters23d
Fact Check: Insulin cap for Medicare unaffected by Trump order on prescription drug costs
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest ...
New York Post24d
Locals near NYC needle exchange site cheer plan to force city to collect used syringes: ‘You clean it up’
Locals near a needle exchange site in a Bronx park are cheering a councilman’s proposal to require city health workers to collect hundreds of discarded syringes littering the ground. Oswald ...
KAAL TV24d
Novo Nordisk insulin now $35 per month for Minnesotans thanks to Attorney General Keith Ellison
(ABC 6 News) – On Monday, Attorney General Keith Ellison announced a settlement with Novo Nordisk that let’s Minnesotans buy its insulin products for $35 per month. For the next five years ...
CBS News24d
Minnesota AG announces Novo Nordisk settlement capping monthly insulin payments at $35
ST. PAUL, Minn. — Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable ...
Fox 924d
Minnesota insulin lawsuit: AG Ellison reaches settlement with Novo Nordisk
The Minnesota Attorney General's Office announced a settlement has been reached with manufacturer Novo Nordisk over the high cost of insulin. The AG's office filed a lawsuit in 2018 against ...
Rick Kupchella's-Bring MeTheNews24d
Settlement secures $35-per-month insulin for all Minnesotans
All Minnesotans, with or without insurance, can buy insulin products for $35 per month, Minnesota Attorney General Keith Ellison announced Monday. A settlement with drug-maker Novo Nordisk resolves ...
Albert Lea Tribune24d
Insulin capped at $35 per month for Minnesotans, after settlement with manufacturers
Minnesotans prescribed insulin won’t pay more than $35 per month for it, after the conclusion of a lawsuit against three major drug manufacturers. Minnesota Attorney General Keith Ellison ...
KIMT24d
All Minnesotans can now get insulin for just $35 a month
ST. PAUL, Minn. – All Minnesotans, whether they have insurance or not, will be able to buy insulin products for $35 a month for the next five years. State Attorney General Keith Ellison says that’s ...